Tavira Therapeutics
The computed 12-month bankruptcy probability of Tavira Therapeutics is 1.5% (low). The 2024 annual accounts show equity of €245k and a net result of €-921k. Its solvency ranks better than 28% of 174 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €245k |
| Net result | €-921k |
| Staff (FTE) | 1 |
| Better than sector | 28% |
Fragile profile, watch profitability in particular.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 22.0% | 55.0% | |
| Net result | €-921k | €16k | |
| Equity | €245k | €70k | |
| Gross operating margin | €-122k | €41k | |
| Staff costs | €21k | €58k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €-143k |
| Net profit | €-921k |
| Cash flow | €-123k |
| Staff costs | €21k |
| Income taxes | €-57k |
| Dividends | - |
| Total assets | €1.11M |
| Equity | €245k |
| Debt | €868k |
| of which ≤ 1y | €84k |
| of which > 1y | €785k |
| Working capital | €351k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 5.19 |
| Quick ratio | 5.19 |
| Working capital ratio | 31.5% |
| Solvency | 22.0% |
| Debt / equity | 3.54 |
| Long-term debt ratio | 3.20 |
| Interest coverage | -3.88 |
| Gross margin | - |
| Net margin | - |
| ROA | -82.7% |
| ROE | -375.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.11M |
| Fixed assets | 21/28 | €679k |
| Intangible fixed assets | 21 | €678k |
| Tangible fixed assets | 22/27 | €991 |
| Current assets | 29/58 | €434k |
| Amounts receivable within one year | 40/41 | €48k |
| Cash & bank | 54/58 | €326k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.11M |
| Equity | 10/15 | €245k |
| Contributions / capital | 10/11 | €1.17M |
| Accumulated profits (losses) | 14 | €-921k |
| Amounts payable | 17/49 | €868k |
| Amounts payable after one year | 17 | €785k |
| Amounts payable within one year | 42/48 | €84k |
| Trade debts payable within one year | 44 | €80k |
| Income statement | ||
| Gross operating margin | 9900 | €-122k |
| Operating result | 9901 | €-941k |
| Financial income | 75 | €220 |
| Financial charges | 65 | €37k |
| Result before taxes | 9903 | €-978k |
| Income taxes | 67/77 | €-57k |
| Net result for the period | 9904 | €-921k |
| Result to be appropriated | 9905 | €-921k |
-
Current08-04-2024 → present
Former directors (1)
-
Former- → 08-04-2024
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| EY Bedrijfsrevisoren BVCurrent Statutory auditor · represented by Eef Naessens |
- | 25-11-2024 → present |
| NACE primary | Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109) |
| Legal form | Private limited company(610) |
| Incorporation | 09-06-2023 |
| Status | Active |
| Postal code | 3001 |
Show 2 more network connections
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24040B0201/00H002 | Flanders | 7,000 m² | 1 · 1,139 m² | 17.0 m · 4 fl. |
| 24040B0218/00V002 | Flanders | 2,297 m² | 1 · 1,484 m² | 2.6 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
05-11-2025 Capital increase of €800,197.80
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 800197.8,
"currency": "EUR",
"after_eur": null,
"delta_eur": 800197.8,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-30",
"evidence_quote": "de beschikbare eigen vermogensrekening van de vennootschap verhoogd werd met een bedrag van achthonderdduizend honderdzevenennegentig komma tachtig euro (\u20AC800.197,80) door uitgifte van tachtigduizend negentien (80.019) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, vertegenwoordigend \u00E9\u00E9n/tweehonderd achtenzeventigduizend negentiende (1/278.019de) van het vennootschapsvermogen, en waarop ingetekend werd door een inbreng in natura van een schuldvordering ten belope van zulk bedrag aan een uitgifteprijs van afgerond tien euro (\u20AC10,00) per aandeel, welke aandelen voor honderd procent (100%) volgestort werden.",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 250000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 250000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-30",
"evidence_quote": "de beschikbare eigen vermogensrekening van de vennootschap verhoogd werd met een bedrag van tweehonderdvijftigduizend euro (\u20AC250.000,00) door uitgifte van vijfentwintigduizend (25.000) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, vertegenwoordigend \u00E9\u00E9n/driehonderdendrieduizend negentiende (1/303.019de) van het vennootschapsvermogen, en waarop ingetekend werd door een inbreng speci\u00EBn ten belope van zulk bedrag aan een uitgifteprijs van tien euro (\u20AC10,00) per aandeel, welke aandelen voor honderd procent (100%) volgestort werden.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0802.591.262",
"name_full": "TAVIRA THERAPEUTICS",
"legal_form": "BV"
}
}25-04-2025 Eef Naessens appointed as statutory auditor
- Eef Naessens, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Eef Naessens",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-11-25",
"evidence_quote": "Het bestuursorgaan beslist op 25 november 2024 om EY Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Kouterveldstraat 7B bus 001, vertegenwoordigd door mevrouw Eef Naessens, 1831 Diegem, Kouterveldstraat 7B bus 001bedrijfsrevisor, te benoemen tot commissaris, voor een termijn van dr"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0802.591.262",
"name_full": "TAVIRA THERAPEUTICS",
"legal_form": "BV"
}
}25-11-2024 Registered office moved within Leuven
- Gaston Geenslaan 1, 3001 Leuven → Gaston Geenslaan 3, 3001 Leuven
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Leuven",
"region": "Vlaams Gewest",
"street": "Gaston Geenslaan",
"country": "BE",
"postcode": "3001",
"box_number": null,
"street_number": "3"
},
"old_address": {
"city": "Leuven",
"region": "Vlaams Gewest",
"street": "Gaston Geenslaan",
"country": "BE",
"postcode": "3001",
"box_number": null,
"street_number": "1"
},
"effective_date": "2023-06-19",
"evidence_quote": "Het bestuursorgaan beslist op 19 juni 2023 een correctie aan te brengen in de notari\u00EBle akte van 9 juni 2023. Het huisnummer van de maatschappelijke zetel van Tavira Therapeutics BV wordt met onmiddellijke ingang gewijzigd naar Gaston Geenslaan 3, 3001 Leuven."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0802.591.262",
"name_full": "TAVIRA THERAPEUTICS",
"legal_form": "BV"
}
}11-04-2024 1 director appointed, 1 resigning
- GEERS, Bart, Bestuurder
- MOEYAERT, Benjamien Roger, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "MOEYAERT, Benjamien Roger",
"address": null,
"birth_date": null
},
"effective_date": "2024-04-08",
"evidence_quote": "- als bestuurder ontslagen werd, met ingang van 8 april 2024: de heer MOEYAERT, Benjamien Roger, wonende te 3001 Heverlee (Leuven), Oud-Heverleestraat 24."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GEERS, Bart",
"address": null,
"birth_date": null
},
"effective_date": "2024-04-08",
"evidence_quote": "- als bestuurder benoemd werd, met ingang van 8 april 2024: de heer GEERS, Bart, wonende te 9111 Belsele (Sint-Niklaas), Ernest Claeslaan 29."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0802.591.262",
"name_full": "TAVIRA THERAPEUTICS",
"legal_form": "BV"
}
}20-06-2023 Capital increase of €350,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 350000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 350000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-06-09",
"evidence_quote": "de beschikbare eigen vermogensrekening verhoogd werd met een bedrag van driehonderdvijftigduizend euro (\u20AC 350.000,00) door uitgifte van vijfendertigduizend (35.000) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, ... en waarop ingetekend werd door een inbreng in speci\u00EBn aan een uitgifteprijs van afgerond tien euro (\u20AC 10,00) per aandeel",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0802.591.262",
"name_full": "TAVIRA THERAPEUTICS",
"legal_form": "BV"
}
}13-06-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Gaston Geenslaan 1, 3001 Heverlee",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "HENCKAERTS, Els Jeanny Vicky",
"niss": null,
"address": "3020 Herent, Brusselsesteenweg 166"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": null,
"holder_person_name": "HENCKAERTS, Els Jeanny Vicky",
"is_subscriber_only": true,
"n_shares_subscribed": null,
"amount_subscribed_eur": null,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "BENOY, Veronick",
"niss": null,
"address": "3384 Glabbeek-Attenrode, Uilekotstraat 3"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": null,
"holder_person_name": "BENOY, Veronick",
"is_subscriber_only": true,
"n_shares_subscribed": null,
"amount_subscribed_eur": null,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "MOEYAERT Benjamien Roger",
"niss": null,
"address": "3001 Heverlee (Leuven), Oud-Heverleestraat 24"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": null,
"holder_person_name": "MOEYAERT Benjamien Roger",
"is_subscriber_only": true,
"n_shares_subscribed": null,
"amount_subscribed_eur": null,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "VAN HOVE Inge",
"niss": null,
"address": "3461 Molenbeek-Wersbeek (Bekkevoort), Leeuwkenstraat 16"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": null,
"holder_person_name": "VAN HOVE Inge",
"is_subscriber_only": true,
"n_shares_subscribed": null,
"amount_subscribed_eur": null,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "TAMBOLI Vibha Kiran",
"niss": null,
"address": "17 Kingscourt Road, Flat 1, SW16 1JA, Londen (Verenigd Koninkrijk)"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": null,
"holder_person_name": "TAMBOLI Vibha Kiran",
"is_subscriber_only": true,
"n_shares_subscribed": null,
"amount_subscribed_eur": null,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 815.0,
"subject_company": {
"kbo": "0802.591.262",
"name_full": "Tavira Therapeutics",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2023-06-09",
"post_incorporation_mandates": []
}| Legal nameNL | Tavira Therapeutics |